Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02750618 · ClinicalTrials.gov registry record · Phase 2

Study of the Safety, Pharmacodynamics (PD) and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH)

A Phase 2 study of X-linked Hypophosphatemia, sponsored by Kyowa Kirin.

Completed
Registry status
Phase 2
Development phase
13
Enrollment target
3
Study locations

NCT02750618 is a Phase 2 study of X-linked Hypophosphatemia that has completed, run by Kyowa Kirin. The registered enrollment target is 13 participants, below the 172-participant average among 5 other X-linked Hypophosphatemia trials with a reported enrollment target (92% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02750618, a Phase 2 study of X-linked Hypophosphatemia, has completed, sponsored by Kyowa Kirin.

COMPLETED
Registry status
Phase 2
Development phase
13 participants
Enrollment target
3
Study locations

Study Summary

The primary objectives of the study are to: * Establish the safety profile of KRN23 for the treatment of XLH in children between 1 and 4 years old * Determine the PD effects of KRN23 treatment on serum phosphorus and other PD markers that reflect the status of phosphate homeostasis in children between 1 and 4 years old with XLH

Conditions Studied

X-linked Hypophosphatemia

Interventions

  • BIOLOGICAL Burosumab

Study Locations (3)

Connecticut

  • Yale University School of Medicine - New Haven

Indiana

  • Indiana University School of Medicine - Indianapolis

Missouri

  • Shriners Hospital for Children - St Louis

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2016-05-05
Est. Completion 2019-09-10
Phase Phase 2

Sponsor

Kyowa Kirin

34 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02750618

The ClinicalTrials.gov registry entry for NCT02750618 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 172-participant average among 5 other X-linked Hypophosphatemia trials with a reported enrollment target (92% lower). The listed sponsor is Kyowa Kirin, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with X-linked Hypophosphatemia appearing as the primary indexed condition, and to 1 intervention - of which Burosumab is the first listed.

NCT02750618 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Connecticut, Indiana, Missouri.

Frequently Asked Questions

What is clinical trial NCT02750618 about?

NCT02750618 is a clinical study titled "Study of the Safety, Pharmacodynamics (PD) and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH)". The primary objectives of the study are to: * Establish the safety profile of KRN23 for the treatment of XLH in children between 1 and 4 years old * Determine the PD effects of KRN23 treatment on serum phosphorus and other PD markers that reflect the status of phosphate homeostasis in children betw...

What is the current status of trial NCT02750618?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 13 participants. The study started on 2016-05-05. Estimated completion is 2019-09-10.

What conditions does trial NCT02750618 study?

This clinical trial studies the following conditions: X-linked Hypophosphatemia.

What interventions are being tested in trial NCT02750618?

The interventions under investigation include: Burosumab (BIOLOGICAL).

Who is sponsoring clinical trial NCT02750618?

This trial is sponsored by Kyowa Kirin, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02750618 being conducted?

This trial has 3 study locations across Connecticut, Indiana, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for X-linked Hypophosphatemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

X-linked Hypophosphatemia

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.